Evidence map›Paper›PMID 10906174›Full record

ArticleJournal of virology2000

Origin of hepatitis delta virus mRNA.

S Gudima, S Y Wu, C M Chiang, G Moraleda, J Taylor

Open access · greenAbstract read
In one paragraph

Article in Journal of virology, 2000. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed, 1 pooled it
1.5field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

41 citing papers in PubMed, 1 synthesis or guideline pooled it, 74 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Medical Advances in Hepatitis D Therapy: Molecular Targets.International journal of molecular sciences · 2022
    Review
  5. Review
  6. Review
  7. Article
  8. Review
  9. Human hepatitis D virus-specific T cell epitopes.JHEP reports : innovation in hepatology · 2021
    Review
  10. HDV-Like Viruses.Viruses · 2021
    Review
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Review
  17. Review
  18. Review
  19. Hepatitis D Virus Replication.Cold Spring Harbor perspectives in medicine · 2015
    Review
  20. Host RNA circles and the origin of hepatitis delta virus.World journal of gastroenterology · 2014
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

S GudimaFox Chase Cancer Center, Philadelphia, Pennsylvania 19111-2497, USA.
S Y Wu
C M Chiang
G Moraleda
J Taylor
Fox Chase Cancer Center · USUniversity of Illinois Urbana-Champaign · US

Funding

WORD PROCESSING CENTER--COREP30CA006927 · NCI · RESEARCH INST OF FOX CHASE CAN CTR · PI Margaret von Mehren · 1985 to 2026
$138.8M
STRUCTURE AND REPLICATION OF HEPATITIS DELTA VIRUSR01AI026522 · NIAID · RESEARCH INST OF FOX CHASE CAN CTR · PI TAYLOR, JOHN MARSTON · 1988 to 2009
$5.1M
ROLE OF CELLULAR PROTEINS IN HPV TRANSCRIPTIONR01CA081017 · NCI · UNIVERSITY OF ILLINOIS URBANA-CHAMPAIGN · PI CHIANG, CHENG-MING · 2000 to 2004
$1.0M
ROLE OF GENERAL COFACTOR IN TAF-INDEPENDENT ACTIVATIONR01GM059643 · NIGMS · UNIVERSITY OF ILLINOIS URBANA-CHAMPAIGN · PI CHIANG, CHENG-MING · 2000 to 2003
$705k
NCI NIH HHS CA-06927NCI NIH HHS CA-81017NCI NIH HHS P30 CA006927NCI NIH HHS R01 CA081017NIAID NIH HHS AI-26522NIAID NIH HHS R01 AI026522NIGMS NIH HHS R01 GM059643
6 · The paper itself

Abstract

Hepatitis delta virus (HDV) is unique relative to all known animal viruses, especially in terms of its ability to redirect host RNA polymerase(s) to transcribe its 1,679-nucleotide (nt) circular RNA genome. During replication there accumulates not only more molecules of the genome but also its exact complement, the antigenome. In addition, there are relatively smaller amounts of an 800-nt RNA of antigenomic polarity that is polyadenylated and considered to act as mRNA for translation of the single and essential HDV protein, the delta antigen. Characterization of this mRNA could provide insights into the in vivo mechanism of HDV RNA-directed RNA transcription and processing. Previously, we showed that the 5' end of this RNA was located in the majority of species, at nt 1630. The present studies show that (i) at least some of this RNA, as extracted from the liver of an HDV-infected woodchuck, behaved as if it contained a 5'-cap structure; (ii) in the infected liver there were additional polyadenylated antigenomic HDV RNA species with 5' ends located at least 202 nt and even 335 nt beyond the nt 1630 site, (iii) the 5' end at nt 1630 was not detected in transfected cells, following DNA-directed HDV RNA transcription, in the absence of genome replication, and (iv) nevertheless, using in vitro transcription with purified human RNA polymerase II holoenzyme and genomic RNA template, we did not detect initiation of template-dependent RNA synthesis; we observed only low levels of 3'-end addition to the template. These new findings support the interpretation that the 5' end detected at nt 1630 during HDV replication represents a specific site for the initiation of an RNA-directed RNA synthesis, which is then modified by capping.

Indexed as

Transcription, GeneticVirus Replication5' Untranslated RegionsAnimalsHepatitis DHepatitis Delta VirusLiverMarmotaReverse Transcriptase Polymerase Chain ReactionRNA CapsRNA, MessengerRNA Polymerase IIRNA, ViralTransfection5' Untranslated RegionsRNA CapsRNA, MessengerRNA Polymerase IIRNA, Viral

Identifiers

PMID10906174
PMCPMC112241
OpenAlexW2149458214

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.